Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Two new Oxford–Bristol Myers Squibb Fellowships will support postdoctoral researchers and clinicians in the Radcliffe Department of Medicine.

Yiangos Psaras and Rupen Hargreaves have been selected as the 2023 Fellows; Christopher Toepfer and Susie Shapiro are the RDM Principal Investigators on the projects, with this being the first time they have been awarded this opportunity.

The Oxford–BMS Fellowship Programme supports postdoctoral fellows carrying out cutting-edge three-year translational projects. Since its establishment in 2015, the programme has supported 37 Fellowships that aim to stimulate new scientific discovery and translation, and generate a cohort of scientists that can navigate within and across academic and industry spheres to bridge translational challenges.

BMS scientists will provide the researchers with critical scientific input to the translational projects, along with mentorship and exposure to the field of commercial drug discovery and development. There will also be opportunities to carry out research and use facilities at BMS labs in the US and Spain.

Read more on the Medical Sciences Division website.